ArticleMolecular carcinogenesis2015

Src is a novel potential off-target of RXR agonists, 9-cis-UAB30 and Targretin, in human breast cancer cells.

Mi-Sung Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.